Ubs Asset Management Americas Inc Zynex Inc Transaction History

Ubs Asset Management Americas Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.53 - $16.8 $203,942 - $359,520	21,400 New	21,400 $256,000
Q3 2022 Nov 14, 2022	BUY	$7.19 - $9.91 $8,297 - $11,436	1,154 New	1,154 $10,000
Q2 2022 Aug 12, 2022	SELL	$5.78 - $8.87 $128,431 - $197,091	-22,220 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.14 - $9.35 $10,382 - $18,887	2,020 Added 10.0%	22,220 $138,000
Q2 2021 Aug 16, 2021	BUY	$12.25 - $14.87 $72,275 - $87,733	5,900 Added 41.26%	20,200 $285,000
Q3 2020 Nov 13, 2020	BUY	$12.98 - $25.98 $40,238 - $80,538	3,100 Added 27.68%	14,300 $226,000
Q2 2020 Aug 14, 2020	BUY	$9.06 - $23.49 $101,472 - $263,088	11,200 New	11,200 $253,000

103

8.4M

200

1.5K

Ticker ZYXI
Exchange NASDAQ
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 37,453,400
Market Cap $293M
Description
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and n...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.